Details of the Drug

General Information of Drug (ID: DMLEHQ3)

• Drug Name: Anti-CEA CAR-T therapy

Indication

Disease Entry	ICD 11	Status	REF
Liver metastasis	2D80	Phase 1	[1]
Metastatic liver cancer	2C12	Phase 1	[2]

• Cross-matching ID: TTD ID: D0OP1L
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)